Chiron Real Estate Inc is a real estate investment trust focused on investing and actively managing critical healthcare infrastructure... Show more
a company, which engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups
Industry PublishingBooksMagazines
A.I.dvisor indicates that over the last year, XRN has been loosely correlated with UDR. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if XRN jumps, then UDR could also see price increases.
| Ticker / NAME | Correlation To XRN | 1D Price Change % | ||
|---|---|---|---|---|
| XRN | 100% | +0.32% | ||
| UDR - XRN | 61% Loosely correlated | +0.21% | ||
| STAG - XRN | 59% Loosely correlated | +0.82% | ||
| IRT - XRN | 59% Loosely correlated | -0.24% | ||
| ESS - XRN | 59% Loosely correlated | +0.45% | ||
| DBRG - XRN | 59% Loosely correlated | +0.13% | ||
More | ||||
XRN saw its Momentum Indicator move above the 0 level on August 13, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned positive. In of the 79 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for XRN just turned positive on August 14, 2026. Looking at past instances where XRN's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .
XRN moved above its 50-day moving average on August 19, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XRN advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .
XRN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for XRN crossed bearishly below the 50-day moving average on August 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XRN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for XRN entered a downward trend on August 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.126) is normal, around the industry mean (3.329). P/E Ratio (9.987) is within average values for comparable stocks, (50.637). XRN's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (3.232). XRN's Dividend Yield (0.154) is considerably higher than the industry average of (0.055). P/S Ratio (3.250) is also within normal values, averaging (6.198).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XRN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock slightly better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.